(Q33577268)

28 July 2017

1 reference

title

Imaging and 'omic' methods for the molecular diagnosis of cancer (English)

1 reference

28 July 2017

Sarah E Bohndiek

1

0 references

Kevin Brindle

series ordinal

2

object named as

Kevin M Brindle

1 reference

28 July 2017

publication date

1 May 2010

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

28 July 2017

published in

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

417-434

1 reference

Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker

28 July 2017

cites work

1 reference

Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers

21 January 2018

1 reference

New approaches for imaging tumour responses to treatment

21 January 2018

1 reference

Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistance

21 January 2018

1 reference

The Hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer

21 January 2018

1 reference

Positron emission tomography as an imaging biomarker

21 January 2018

1 reference

PET/CT for the staging and follow-up of patients with malignancies

21 January 2018

1 reference

PET/CT: form and function

21 January 2018

1 reference

How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study.

21 January 2018

1 reference

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.

21 January 2018

1 reference

FDG-PET and CT characterization of adrenal lesions in cancer patients.

21 January 2018

1 reference

2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer

21 January 2018

1 reference

The impact of 18F-FDG PET/CT in patients with liver metastases.

21 January 2018

1 reference

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

21 January 2018

1 reference

Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET.

21 January 2018

1 reference

Standard uptake value predicts survival in non-small cell lung cancer.

21 January 2018

1 reference

Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesions

21 January 2018

1 reference

Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer.

21 January 2018

1 reference

Intense esophageal FDG activity caused by Candida infection obscured the concurrent primary esophageal cancer on PET imaging

21 January 2018

1 reference

11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

21 January 2018

1 reference

The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.

21 January 2018

1 reference

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

21 January 2018

1 reference

Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

21 January 2018

1 reference

Evaluation of O-[(18)F]fluoromethyl-D-tyrosine as a radiotracer for tumor imaging with positron emission tomography

21 January 2018

1 reference

Synthesis and evaluation of novel F-18 labeled fluoroarylvaline derivatives: potential PET imaging agents for tumor detection

21 January 2018

1 reference

Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques

21 January 2018

1 reference

Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation.

21 January 2018

1 reference

11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma

21 January 2018

1 reference

PET imaging of brain astrocytoma with 1-11C-acetate

21 January 2018

1 reference

11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.

21 January 2018

1 reference

PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective

21 January 2018

1 reference

[(18)F]Fluoroacetate is not a functional analogue of [(11)C]acetate in normal physiology.

21 January 2018

1 reference

Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine

21 January 2018

1 reference

[18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors

21 January 2018

1 reference

Clinical relevance of imaging proliferative activity in lung nodules

21 January 2018

1 reference

Molecular imaging of proliferation in malignant lymphoma.

21 January 2018

1 reference

A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.

21 January 2018

1 reference

Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer

21 January 2018

1 reference

Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).

21 January 2018

1 reference

Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide

21 January 2018

1 reference

[18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98.

21 January 2018

1 reference

Molecular imaging of cell death

21 January 2018

1 reference

Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent.

21 January 2018

1 reference

Sigma receptors and cancer: possible involvement of ion channels

21 January 2018

1 reference

Carbon-11 labeled sigma2 receptor ligands for imaging breast cancer

21 January 2018

1 reference

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.

21 January 2018

1 reference

Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?

21 January 2018

1 reference

(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging

21 January 2018

1 reference

Latest advances in molecular imaging instrumentation

21 January 2018

1 reference

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response

21 January 2018

1 reference

Proton MRS of the breast in the clinical setting

21 January 2018

1 reference

Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.

21 January 2018

1 reference

Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications

21 January 2018

1 reference

In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry.

21 January 2018

1 reference

Proton magnetic resonance spectroscopy of brain tumors correlated with pathology

21 January 2018

1 reference

Proton MRS imaging in the follow-up of patients with suspected low-grade gliomas

21 January 2018

1 reference

Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.

21 January 2018

1 reference

Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas

21 January 2018

1 reference

Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra.

21 January 2018

1 reference

Applications of magnetic resonance spectroscopy in radiotherapy treatment planning.

21 January 2018

1 reference

Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.

21 January 2018

1 reference

MRI and (1)H MRS of the breast: presence of a choline peak as malignancy marker is related to K21 value of the tumor in patients with invasive ductal carcinoma

21 January 2018

1 reference

In vivo proton magnetic resonance spectroscopy of breast lesions: an update.

21 January 2018

1 reference

Metabolite quantification and high-field MRS in breast cancer

21 January 2018

1 reference

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy

21 January 2018

1 reference

Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study

21 January 2018

1 reference

Study of normal breast tissue by in vivo volume localized proton MR spectroscopy: variation of water-fat ratio in relation to the heterogeneity of the breast and the menstrual cycle.

21 January 2018

1 reference

Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging

21 January 2018

1 reference

Proton MR spectroscopy of the prostate

21 January 2018

1 reference

Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate

21 January 2018

1 reference

Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathology

21 January 2018

1 reference

Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy

21 January 2018

1 reference

Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR

21 January 2018

1 reference

Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading

21 January 2018

1 reference

Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

21 January 2018

1 reference

Generation of hyperpolarized substrates by secondary labeling with [1,1-13C] acetic anhydride

21 January 2018

1 reference

The cancer biomarker problem

21 January 2018

1 reference

Genomics and proteomics: emerging technologies in clinical cancer research.

21 January 2018

1 reference

Prediction of breast cancer metastasis by genomic profiling: where do we stand?

21 January 2018

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

Trial assessing individualized options for treatment for breast cancer: the TAILORx trial

21 January 2018

1 reference

Gene-expression signatures in breast cancer

21 January 2018

1 reference

New molecular classifications of breast cancer

21 January 2018

1 reference

A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects

21 January 2018

1 reference

Functional genomics of hepatocellular carcinoma

21 January 2018

1 reference

Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis

21 January 2018

1 reference

An integrated cross-platform prognosis study on neuroblastoma patients

21 January 2018

1 reference

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

21 January 2018

1 reference

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

Utilization of genomic signatures to direct use of primary chemotherapy

21 January 2018

1 reference

A novel approach for reliable microarray analysis of microdissected tumor cells from formalin-fixed and paraffin-embedded colorectal cancer resection specimens.

21 January 2018

1 reference

Identification of methods for use of formalin-fixed, paraffin-embedded tissue samples in RNA expression profiling.

21 January 2018

1 reference

Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification

21 January 2018

1 reference

Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues

21 January 2018

1 reference

MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling.

21 January 2018

1 reference

MicroRNAs accurately identify cancer tissue origin

21 January 2018

1 reference

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma

21 January 2018

1 reference

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

21 January 2018

1 reference

Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist

21 January 2018

1 reference

21 January 2018

Epigenetics in cancer

1 reference

PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment

21 January 2018

1 reference

A longitudinal study of gene expression in healthy individuals

21 January 2018

1 reference

Risk of developing prostate cancer in the future: overview of prognostic biomarkers.

21 January 2018

1 reference

Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients

21 January 2018

1 reference

Active surveillance for prostate cancer: for whom?

21 January 2018

1 reference

Repeat prostate biopsy--when, where, and how.

21 January 2018

1 reference

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

21 January 2018

1 reference

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

21 January 2018

1 reference

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

21 January 2018

1 reference

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

21 January 2018

1 reference

Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.

21 January 2018

1 reference

Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker

21 January 2018

1 reference

Quantitative biochemical analysis of lactate dehydrogenase in human ovarian tissues: correlation with tumor grade

21 January 2018

1 reference

Review: Biological relevance of disseminated tumor cells in cancer patients

21 January 2018

1 reference

Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma

21 January 2018

1 reference

Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases

21 January 2018

1 reference

Mass spectrometry in clinical proteomics - from the present to the future.

21 January 2018

1 reference

Panel of serum biomarkers for the diagnosis of lung cancer

21 January 2018

1 reference

Highly sensitive detection of melanoma based on serum proteomic profiling.

21 January 2018

1 reference

Characterization of serum biomarkers for detection of early stage ovarian cancer

21 January 2018

1 reference

Salivary proteomics for oral cancer biomarker discovery

21 January 2018

1 reference

Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review

21 January 2018

1 reference

Prostate cancer biomarker discovery using high performance mass spectral serum profiling

21 January 2018

1 reference

Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.

21 January 2018

1 reference

Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias

21 January 2018

1 reference

Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.

21 January 2018

1 reference

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.

21 January 2018

1 reference

Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer

21 January 2018

1 reference

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

21 January 2018

1 reference

Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis

21 January 2018

1 reference

Abnormal Choline Phospholipid Metabolism in Breast and Ovary Cancer:Molecular Bases for Noninvasive Imaging Approaches

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.10.20

1 reference

28 July 2017

1 reference